Table 1.
Baseline parameters of the enrolled cohort.
| Overall Cohort | Male | Female | |
|---|---|---|---|
| n | 50 | 10 | 40 |
| Age (years) | 36.9 ± 12.8 | 30.5 ± 12.1 | 38.5 ± 12.6 |
| BMI (Kg/m2) | 30.6 ± 2.0 | 30.3 ± 1.8 | 30.7 ± 2.1 |
| WC (cm) | 102.1 ± 4.1 | 105.0 ± 3.2 | 101.4 ± 4.1 |
| HOMA index | 4.5 ± 1.2 | 5.5 ± 0.9 | 4.2 ± 1.1 |
| TSH (µIU/mL) | 2.9 ± 0.6 | 3.6 ± 0.3 | 2.8 ± 0.6 |
| FT4 (pmol/L) | 10.1 ± 1.8 | 9.5 ± 1.0 | 10.2 ± 1.9 |
| FT3 (pmol/L) | 4.7 ± 0.6 | 4.3 ± 0.4 | 4.9 ± 0.6 |
| Thyroid volume (mL) | 22.2 ± 2.8 | 21.3 ± 3.4 | 22.4 ± 2.6 |
| Nodule volume (mL) | 2.5 ± 0.6 | 3.0 ± 0.6 | 2.3 ± 0.6 |
Data are reported as mean ± SD; BMI, body mass index; WC, waist circumference; HOMA, homeostatic model assessment; TSH, thyroid stimulating hormone; FT4, thyroxin; FT3, free-triiodothyronine.